Cargando…
Estimating the Demand for a Preventive HIV Vaccine: Why We Need to Do Better: Reliable estimates would help in achieving several policy and advocacy objectives
Additional research on public and private demand for HIV vaccines is needed to strengthen ongoing advocacy and planning for eventual vaccine introduction, say Hecht and Suraratdecha.
Autores principales: | Hecht, Robert, Suraratdecha, Chutima |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560173/ https://www.ncbi.nlm.nih.gov/pubmed/16953657 http://dx.doi.org/10.1371/journal.pmed.0030398 |
Ejemplares similares
-
New Methodology for Estimating the Burden of Infectious Diseases in Europe
por: Kretzschmar, Mirjam, et al.
Publicado: (2012) -
Managing the Demand for Global Health Education
por: Kerry, Vanessa B., et al.
Publicado: (2011) -
The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States
por: Gagnon, Marc-André, et al.
Publicado: (2008) -
Financing Maternal and Child Health—What Are the Limitations in Estimating Donor Flows and Resource Needs?
por: Schäferhoff, Marco, et al.
Publicado: (2010) -
How Should Treatment Decisions Be Made for Incapacitated Patients, and Why?
por: Shalowitz, David I, et al.
Publicado: (2007)